Global companies have made notable progress in diversifying their financial strategies and adopting compliant custody solutions, according to ChainCatcher. Key developments include Acurx Pharmaceuticals' board approval of a $10 million Bitcoin purchase to hedge against inflation risks affecting long-term research funds. Enfusion has updated its financial guidelines to allocate 10% of its surplus cash into Bitcoin and Ethereum, aiming to enhance the risk-adjusted returns of its treasury. Nature's Miracle has initiated a $5 million Bitcoin strategic treasury plan, marking a significant step for agritech firms in accepting cryptocurrency as a reserve currency. Additionally, Bakkt's Q4 forecast indicates a 40% year-over-year increase in enterprise-level crypto asset custody, highlighting the growing reliance on compliant third-party custodians by non-native crypto companies entering the market.